OK SB737

Prohibits pharmacists from substituting or interchanging opioid analgesic drugs for FDA-approved abuse-deterrent opioid products when a generic equivalent for abuse-deterrent opioids is available under Oklahoma Medicaid.

Defines "opioid analgesic drug with abuse-deterrent properties" as products determined by the FDA based on incorporation of abuse-deterrent technology and sufficient evidence supporting abuse-deterrent labeling claims.

Allows interchangeability between two abuse-deterrent opioid products if they have the same level of FDA-approved abuse-deterrence labeling claims, without requiring identical abuse-deterrence methods.

Applies only to prescriptions covered by the Oklahoma Medicaid Program and takes effect following FDA approval of a generic equivalent for an abuse-deterrent opioid product.

Becomes effective November 1, 2015.